Action KAYS KAYA HOLDINGS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Kaya Holdings, Inc.

Actions

KAYS

US4865672095

Temps Différé OTC Markets
Autres places de cotation
 15:30:02 03/05/2024 		Varia. 5j. Varia. 1 janv.
0,035 USD -7,89% Graphique intraday de Kaya Holdings, Inc. -18,60% -16,86%
16/04 Kaya Holdings, Inc. annonce ses résultats pour l'exercice clos le 31 décembre 2023 CI
2023 Kaya Holdings, Inc. annonce ses résultats pour le troisième trimestre et les neuf mois terminés le 30 septembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Investor Ideas Potcasts: Interview with Kaya Holdings on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Pioneers and Innovators in Psilocybin Treatments and How Big Pharma Wants in on the Game
Kaya Holdings, Inc. Secures Site for the Sacred Mushroom(TM) Planned Psilocybin Treatment Center
Kaya Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Kaya Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
KAYA HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Kaya Holdings, Inc. Auditor Raises 'Going Concern' Doubt
Kaya : Acquisition/Asset Disposal - Form 8-K
KAYA HOLDINGS, INC. : Completion of Acquisition or Disposition of Assets (form 8-K)
KAYA HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
KAYA HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Kaya Holdings, Inc. Launches Fifth Dimension Therapeutics to Seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market
KAYA HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
KAYA HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Kaya : to Seek Licenses for First Ever State Legal Psilocybin Manufacturing and Facilitation Service Centers in Oregon
Kaya : Cannabis Company Kaya Holdings, Inc’s Greek Joint Venture Receives Crucial Installation License for 50K Sq. Ft. Medical Cannabis Facility in Epidaurus, Greece - Form 8-K
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action KAYS
  4. Actualités Kaya Holdings, Inc.
  5. Autres langues